NEW YORK, Sept. 19 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX - News) announced today that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, is scheduled to present at the Oppenheimer & Co. Second Annual Diabetes Conference. Mr. Weiss’ presentation will take place on Thursday, September 21, 2006 at 1:00 pm ET at The Jolly Hotel, Madison Towers, in New York City.
